Newsroom

Healthcare Pharmaceutical Biotech

Stay informed with the latest in Healthcare, Pharmaceutical and Biotech press releases through our newsroom. Explore breaking updates, industry trends, and insights shaping these vital sectors—all in one place. Whether it’s innovation, regulatory changes, or breakthroughs, our newsroom keeps you connected to the stories that matter most.

All News

UN-Affiliated Health Organization Appoints Dr. Anosh Ahmed to Develop COVID-19 Testing and Vaccination Standards for Northern Africa
Healthcare & PharmaceuticalPartnerships

UN-Affiliated Health Organization Appoints Dr. Anosh Ahmed to Develop COVID-19 Testing and Vaccination Standards for Northern Africa

July 4, 2025 7:00 AM

Dr. Anosh Ahmed has been officially appointed by a UN-affiliated healthcare organization to develop standardized protocols for COVID-19 testing, vaccination, and related field operations in underserved regions of Northern Africa. This initiative is part of broader international efforts aimed at strengthening health systems in areas experiencing limited infrastructure and ongoing recovery challenges.Dr. Anosh Ahmed, global health protocol...

Read more
DEA's Thomas Prevoznik Fails Again: Cannabis Users Poisoned While Pharmaceutical Cannabis Remains Blocked
Healthcare & PharmaceuticalCompany Update

DEA's Thomas Prevoznik Fails Again: Cannabis Users Poisoned While Pharmaceutical Cannabis Remains Blocked

July 4, 2025 5:00 AM

The Drug Enforcement Administration (DEA) is asleep at the wheel - or worse, willfully negligent - as contaminated cannabis floods state markets, consumers are poisoned, and legitimate pharmaceutical research is actively blocked by the very agency tasked with protecting public health. At the center of this national disgrace is DEA's Deputy Administrator Thomas Prevoznik, the long-time bureaucrat at the helm of the DEA's Diversion Control...

Read more
My Compounding Pharmacy for Pediatricians: Personalized Medicine Solutions for Children Across Australia
Healthcare & PharmaceuticalCompany Update

My Compounding Pharmacy for Pediatricians: Personalized Medicine Solutions for Children Across Australia

July 3, 2025 4:50 PM

Parenting comes with many challenges, and one of the unexpected hurdles can be ensuring your child takes their prescribed medication. Whether it's due to unpleasant tastes, difficulty swallowing pills, or sensitivities to certain ingredients, many parents struggle to administer standard medications. This is where Australia's My Compounding Pharmacy steps in, transforming pediatric medicine through innovative, personalized solutions.Why...

Read more
Workflow Efficiency Performance Widens Among Inpatient EHR Leaders, Q3 2025 Black Book Report
Healthcare & PharmaceuticalCompany Update

Workflow Efficiency Performance Widens Among Inpatient EHR Leaders, Q3 2025 Black Book Report

July 3, 2025 2:00 PM

With workflow efficiency now a top strategic priority for health systems responding to clinician burnout, workforce constraints, and operational performance pressures, a new Black Book Research survey of 409 US inpatient EHR users reveals meaningful disparities in satisfaction across major inpatient EHR platforms, and dramatic shifts for some since 2018.Workflow efficiency, as defined by hospital users, includes enhancements in documentation...

Read more
Frank's Team Shows They Care During His Time of Need
Healthcare & PharmaceuticalEnvironmental, Social and Governance

Frank's Team Shows They Care During His Time of Need

July 3, 2025 1:35 PM

Frank's teammates really stepped up during his time of need and showed they genuinely care about him. That's the DaVita Difference.About DaVita Inc.DaVita (NYSE:DVA) is a health care provider focused on transforming care delivery to improve quality of life for patients globally. As a comprehensive kidney care provider, DaVita has been a leader in clinical quality and innovation for 25 years. DaVita cares for patients at every stage and setting...

Read more
MDCE's RGU Explodes in Popularity, Patent Pending Status Weeks Away
Healthcare & PharmaceuticalCompany Update

MDCE's RGU Explodes in Popularity, Patent Pending Status Weeks Away

July 3, 2025 9:30 AM

Medical Care Technologies Inc. (OTC Pink:MDCE) today announced that its subsidiary, Real Game Used (RGU), is experiencing an unprecedented surge in submissions due to viral demand following a series of high-profile AI-driven photo match discoveries.Meanwhile, RGU's U.S. utility patent application has officially passed Stage One review, with formal patent pending status expected within the next 3 weeks. This milestone validates the unique nature...

Read more
NerveCalm Reviews 2025: Ingredients, Real User Results, Pros and Cons! (What You Should Know)
Healthcare & PharmaceuticalCompany Update

NerveCalm Reviews 2025: Ingredients, Real User Results, Pros and Cons! (What You Should Know)

July 3, 2025 8:55 AM

If you've ever experienced nerve discomfort-those strange tingles, restless nights, constant tiredness, or a lingering mental fog-you're definitely not alone. I've been through it myself. It's not just about the physical discomfort; over time, it begins to take a serious emotional toll. Sleep becomes elusive, your energy fades, and that peaceful state of mind we all rely on starts to slip away.Modern life doesn't make things any easier. From...

Read more
UTILITY Therapeutics Announces Acquisition by Alembic Pharmaceuticals Inc.
Healthcare & PharmaceuticalMergers and Acquisitions

UTILITY Therapeutics Announces Acquisition by Alembic Pharmaceuticals Inc.

July 3, 2025 8:45 AM

UTILITY therapeutics Ltd. (UTILITY), a biotechnology company focused on the development of PIVYA (pivmecillinam 185 mg tablets), a penicillin class antibacterial approved by the U.S. Food and Drug Administration (FDA) for the treatment of uncomplicated urinary tract infection (uUTI), today announced that it has been acquired by Alembic Pharmaceuticals, Inc. (Alembic).PIVYA marked the first antibiotic in approximately 20 years to earn FDA...

Read more
MIRA Reports Potent Inflammatory Pain Relief from Non-Psychoactive Marijuana Analog Mira-55 in Animal Model, Matching Morphine Without Opioid Risks
Healthcare & PharmaceuticalCompany Update

MIRA Reports Potent Inflammatory Pain Relief from Non-Psychoactive Marijuana Analog Mira-55 in Animal Model, Matching Morphine Without Opioid Risks

July 3, 2025 8:00 AM

MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA) ("MIRA" or the "Company"), a clinical-stage pharmaceutical company developing novel therapeutics for neurologic, neuropsychiatric, and metabolic disorders, today announced positive preclinical data demonstrating that Mira-55, the Company's proprietary non-psychotropic marijuana analog, delivered morphine-comparable pain relief in a validated model of inflammatory pain-without causing local...

Read more
The Versailles Hospital Center Chooses Tribun Health for Its Transition to Digital Pathology
Healthcare & PharmaceuticalCompany Update

The Versailles Hospital Center Chooses Tribun Health for Its Transition to Digital Pathology

July 3, 2025 8:00 AM

Tribun Health, European leader in AI-enhanced digital pathology, is proud to announce that the Versailles Hospital Center, the supporting institution of GHT 78 Sud, has selected its imaging platform, CaloPix®, to support the digital transformation of its pathology department.This decision represents a strategic milestone in modernizing diagnostic services within the French public healthcare system. Through this project, the Versailles Hospital...

Read more
Joint Genesis Reviews (2025 UPDATE) Ingredients, Benefits, Real Results, and Buyer's Guide
Healthcare & PharmaceuticalCompany Update

Joint Genesis Reviews (2025 UPDATE) Ingredients, Benefits, Real Results, and Buyer's Guide

July 3, 2025 7:55 AM

If you struggle with joint pain, stiffness, or limited mobility, you're definitely not alone. Many people are now turning to natural supplements in hopes of finding lasting relief. One supplement that's been gaining attention lately is Joint Genesis. It's being promoted as a powerful joint support formula designed to help people move more comfortably, without relying on risky medications or undergoing invasive procedures. Joint Genesis stands...

Read more
Darren Waller Returns to NFL With the Dolphins - Brings Addiction Recovery Mission With Him
Healthcare & PharmaceuticalPartnerships

Darren Waller Returns to NFL With the Dolphins - Brings Addiction Recovery Mission With Him

July 3, 2025 6:00 AM

Pro Bowl tight end Darren Waller is returning to the NFL, signing with the Miami Dolphins in what fans are calling one of the most exciting comebacks in recent years. But for Waller, this return isn't just about football - it's about purpose, recovery, and service to something greater than himself."I've been in my growth journey since rehab," says Waller, who nearly lost his life to a fentanyl overdose eight years ago. "Recovery isn't just about...

Read more
Sweden, the Czech Republic, and Greece Crowned Champions of Harm Reduction in Brussels
Healthcare & PharmaceuticalAwards

Sweden, the Czech Republic, and Greece Crowned Champions of Harm Reduction in Brussels

July 3, 2025 12:00 AM

Brussels transformed into a Champions League pitch for tobacco harm reduction as the World Vapers' Alliance (WVA) honoured Sweden, the Czech Republic, and Greece with the "Champions of Change" trophy for their outstanding progress in cutting smoking rates. The ceremony, staged in front of the European Parliament, shone a spotlight on the countries leading Europe's fight against smoking-while EU officials looked on from the sidelines.WVA Director...

Read more
Onco-Innovations CEO Highlights Strategic Milestones and R&D Progress in Special Investors' Conference Call
Healthcare & PharmaceuticalCompany Update

Onco-Innovations CEO Highlights Strategic Milestones and R&D Progress in Special Investors' Conference Call

July 2, 2025 6:30 PM

Onco-Innovations Limited (CBOE CA:ONCO)(OTCQB:ONNVF)(Frankfurt:W1H,WKN:A3EKSZ) ("Onco" or the "Company") is pleased to announce that on July 2, 2025, its Chief Executive Officer, Thomas O'Shaughnessy, held an investor call during which he provided shareholders with an update on the Company's strategic milestones and development roadmap, as it continues to advance its mission to accelerate cancer treatment innovation through cutting-edge...

Read more
Bay Area CBT Center Introduces Transformative Customized Couples Retreats for Relationship Growth and Healing
Healthcare & PharmaceuticalProduct Announcements

Bay Area CBT Center Introduces Transformative Customized Couples Retreats for Relationship Growth and Healing

July 2, 2025 3:05 PM

The Bay Area CBT Center has unveiled a groundbreaking offering: fully customized couples retreats designed to help partners rebuild trust, repair emotional wounds, and rekindle intimacy. These retreats go far beyond traditional wellness retreats - they're immersive, evidence-based experiences led by licensed therapists and tailored entirely to the specific dynamics of each relationship. Whether you're recovering from betrayal, feeling...

Read more
Larineco Reviews: Does This Remineralizing Gum Really Work?
Healthcare & PharmaceuticalCompany Update

Larineco Reviews: Does This Remineralizing Gum Really Work?

July 2, 2025 2:15 PM

Have you ever pondered whether chewing gum could be used for purposes other than breath freshening? We thought about it too, so decided to learn more about Larineco, a gum that claims to promote tooth health in ways other than just minty taste. It promises to use minerals like Xylitol, Mastic, and Nano Hydroxyapatite to help with everything from plaque reduction to enamel repair. A meticulous oral care plan may not be possible owing to your...

Read more
Neuriva Review - Is There a Better Brain Supplement?
Healthcare & PharmaceuticalCompany Update

Neuriva Review - Is There a Better Brain Supplement?

July 2, 2025 11:30 AM

Does Neuriva work? This Neuriva review sets out to find just the answer to that very question. Neuriva is a brain supplement that is designed to improve brain performance in healthy adults, mainly through the use of coffee cherry extract and phosphatidylserine. Let's find out just how effective this brain supplement for memory is.Our Best Brain Supplements Rated:The TLDR is that Neuriva is not a great supplement for brain health. These...

Read more
The Extraordinary General Meeting of AlzeCure Pharma AB Approved the Decision on the New Issue of Shares
Healthcare & PharmaceuticalShareholder Meeting

The Extraordinary General Meeting of AlzeCure Pharma AB Approved the Decision on the New Issue of Shares

July 2, 2025 10:25 AM

STOCKHOLM, SE / ACCESS Newswire / July 2, 2025 / AlzeCure Pharma (STO:ALZCUR)(FRA:AC6) - At an extraordinary general meeting in AlzeCure Pharma AB on July 2, 2025, the shareholders decided to approve the board's previous decision on the preferential issue of shares.The general meeting approved the board's previous decision of June 16, 2025 regarding the preferential issue of shares on the following main terms:The company's share capital must be...

Read more
MDCE to Cancel 680 Million CEO Shares and Slash 980 Million Authorized Shares as Stock Trades Near 52-Week Low; Q2 Rebound Underway
Healthcare & PharmaceuticalCompany Update

MDCE to Cancel 680 Million CEO Shares and Slash 980 Million Authorized Shares as Stock Trades Near 52-Week Low; Q2 Rebound Underway

July 2, 2025 9:30 AM

Medical Care Technologies Inc. (OTC Pink:MDCE ) today announced an aggressive two-part share structure reduction plan aimed at restoring shareholder confidence and positioning the company for long-term growth. The announcement comes as MDCE trades near its 52-week low, while management confirms that Q2 closed with a stronger-than-expected rebound , to be detailed in the upcoming quarterly report.As part of the restructuring, the Company...

Read more
Backing the Future of Preemptive Health: Glen Ventures Leads Investment in Sensifai Health
Healthcare & PharmaceuticalFinancing

Backing the Future of Preemptive Health: Glen Ventures Leads Investment in Sensifai Health

July 2, 2025 9:00 AM

Glen Ventures is proud to announce it has led the seed investment round in Sensifai Health, with major contribution from the Eurêka investment fund. Sensifai is a Montreal-based bioconvergence startup emerging from stealth with a groundbreaking AI platform for preemptive health.The company's technology, originating from work conducted at the Research Institute of the McGill University Health Centre (RI-MUHC), is the first to harness...

Read more

Join the thousands of ACCESS Newswire customers today who are getting millions of views on their news.


Check out our flexible subscription and pay as you go pricing

and packages.

Use Code NEWS10 for 10% off  of your first purchase.


Latest Blog Posts

Visit our blogs for press release tips, media engagement

Strategies, and Product Comparisons.

Executive delivering prepared remarks from an earnings call script
By Jennifer Hammers July 9, 2026
How to write earnings call prepared remarks that land — structure, length, the safe-harbor open, non-GAAP language, and building remarks around your strategy.
IR
By Brian Balbirnie July 8, 2026
A practical earnings call preparation checklist for IR teams — the two-week runway, consensus, logistics, Q&A prep, and Reg FD-clean disclosure timing.
ACCESS Newswire guide on AI investor relations — how AI assistants read company earnings disclosures
By Jennifer Hammers July 6, 2026
AI assistants read your earnings within minutes. Learn how IR teams make disclosures AI-readable — and how the LLM Citation Score measures your visibility.
What does Meltwater cost in 2026, and what are the alternatives? Meltwater resells press release dis
By Jennifer Hammers June 22, 2026
What does Meltwater cost in 2026, and what are the alternatives? See how ACCESS Newswire compares on distribution, data, and price.
A logo for accesswire next to a logo for rack
By Jennifer Hammers June 21, 2026
Compare Muck Rack vs ACCESS Newswire on pricing, features, and alternatives. See how ACCESS Newswire adds distribution, pitching, and analytics.
A blue and white logo with a check mark next to it
By Jennifer Hammers June 19, 2026
Compare Business Wire vs ACCESS Newswire on pricing and capabilities — and how ACCESS delivers comparable reach at a fraction of the cost.
Show More




Discover the news
by Industry:


Need help with your PR Strategy?
Learn more about our
professional PR Services today:

.MEDIA PRO 
Want to get noticed
by the Media but don’t
know how? 

.TOTAL PRO

Need full support to 

Optimize your PR

Efforts?